ARS Pharmaceuticals (SPRY) Other Non Operating Income (2022 - 2026)
ARS Pharmaceuticals' Other Non Operating Income was $2.48 million in Q2 2026, down 9.2% from $2.73 million a year earlier but up 1.6% from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Other Non Operating Income (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, ARS Pharmaceuticals' Other Non Operating Income was $9.62 million through Jun 30, 2026, down 17.2% year-over-year; for FY2025, it came in at $10.67 million, down 6.2% from FY2024.
- In earlier years, Other Non Operating Income was $11.37 million in FY2024 (-13.6%), $13.16 million in FY2023, $974,000 in FY2022 and -$789,000 in FY2021.
- Quarterly Other Non Operating Income has moved between -$151,000 (Q1 2022) and $3.75 million (Q1 2023) over five years.
- Compared with a year earlier, Other Non Operating Income has declined for five straight quarters, with an average decline of 9.6% over the last eight quarters.
- The best year-over-year quarter for Other Non Operating Income over five years was Q4 2023 (growth of 165.0%); the worst was Q1 2026 (a decline of 24.6%).
- Per Business Quant data, SPRY's Other Non Operating Income in the three quarters before Q2 2026 was $2.44 million (Q1 2026), $2.66 million (Q4 2025) and $2.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | ARS Pharmaceuticals | 409.68 Mn | 265.88 Mn | 20.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.48 Mn |
| Mar 31, 2026 | 2.44 Mn |
| Dec 31, 2025 | 2.66 Mn |
| Sep 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Mar 31, 2025 | 3.24 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Sep 30, 2024 | 2.62 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Dec 31, 2023 | 3.06 Mn |
| Sep 30, 2023 | 3.11 Mn |
| Jun 30, 2023 | 3.23 Mn |
| Mar 31, 2023 | 3.75 Mn |
| Dec 31, 2022 | 1.15 Mn |
| Sep 30, 2022 | 47,000.00 |
| Jun 30, 2022 | -76,000.00 |
| Mar 31, 2022 | -151,000.00 |
API Access
ARS Pharmaceuticals Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();